Company profile
Corix Bioscience, Inc.
OTC: CXBS · Healthcare · Medical - Pharmaceuticals
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 19
v0.1 · 5/100 weight · pillars only
↑ listing tenure, market scale · ↓ workforce scale, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
2
as of 2026-08-03
Market cap
$2.7k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Corix Bioscience, Inc.’s financial profile?
Corix Bioscience, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Skylight Health Group Inc.——ER Urgent Care Holdings, Inc.——Rebus Holdings, Inc.——Southwestern Medical Solutions, Inc.——Longport, Inc.——CanaQuest Medical Corp.——Neighbors
Maricopa →Key facts
CEOChrist Froese
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersPhoenix, AZ
ExchangeOTC: CXBS
Employees2
IPO date2017-03-14
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.